Published in J Clin Invest on October 12, 2015
Hallmarks of Tissue-Resident Lymphocytes. Cell (2016) 1.10
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol (2016) 0.94
Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol (2016) 0.92
MAIT cells are activated during human viral infections. Nat Commun (2016) 0.86
MAIT cells: new guardians of the liver. Clin Transl Immunology (2016) 0.79
Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology (2016) 0.78
Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations. J Immunol (2017) 0.76
Close Encounters of Lymphoid Cells and Bacteria. Front Immunol (2016) 0.75
High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget (2016) 0.75
MAIT cells promote inflammatory monocyte differentiation into dendritic cells during pulmonary intracellular infection. J Exp Med (2016) 0.75
The dynamics of mucosal-associated invariant T cells in multiple sclerosis. Springerplus (2016) 0.75
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol (2017) 0.75
MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Immunogenetics (2016) 0.75
FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics (2011) 13.71
Mouse genomic variation and its effect on phenotypes and gene regulation. Nature (2011) 10.66
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun (2001) 4.82
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 4.25
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med (2008) 3.85
MR1 presents microbial vitamin B metabolites to MAIT cells. Nature (2012) 3.71
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med (1994) 3.47
Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol (2009) 3.38
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity (2009) 2.64
Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. Nat Immunol (2002) 2.46
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A (2010) 2.19
A murine model of urinary tract infection. Nat Protoc (2009) 2.15
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med (2013) 2.04
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol (2011) 2.01
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature (2014) 1.76
Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol (2006) 1.72
CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol (2013) 1.72
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun (2013) 1.71
Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun (2012) 1.69
MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol (2006) 1.69
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood (2012) 1.69
The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol (2010) 1.68
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol (2014) 1.66
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood (2012) 1.60
IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol (2013) 1.57
Premature expression of T cell receptor (TCR)alphabeta suppresses TCRgammadelta gene rearrangement but permits development of gammadelta lineage T cells. J Exp Med (2000) 1.55
MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci U S A (2013) 1.54
CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain (2011) 1.53
The mouse (Mus musculus) T cell receptor alpha (TRA) and delta (TRD) variable genes. Dev Comp Immunol (2003) 1.43
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med (2000) 1.38
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun (2014) 1.32
MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol (2013) 1.30
CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep (2014) 1.28
Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun (2014) 1.21
Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells. Blood (2011) 1.16
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol (2014) 1.13
Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans. J Immunol (2010) 1.11
Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med (2015) 1.09
Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One (2013) 1.06
Double-positive thymocytes select mucosal-associated invariant T cells. J Immunol (2013) 1.05
Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans. Mol Cell Biol (2012) 1.04
In Vitro and In Vivo Analysis of the Gram-Negative Bacteria-Derived Riboflavin Precursor Derivatives Activating Mouse MAIT Cells. J Immunol (2015) 0.98
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. J Immunol (2015) 0.96
NKT cell depletion in humans during early HIV infection. Immunol Cell Biol (2014) 0.85
Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells. Int Immunol (2012) 0.83
Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation. Immunol Lett (2008) 0.79
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med (2002) 6.25
Origin of the lamina propria dendritic cell network. Immunity (2009) 5.95
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol (2009) 5.83
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol (2011) 5.14
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 4.25
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol (2002) 3.78
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol (2010) 3.76
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med (2011) 2.48
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med (2005) 2.33
Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25
Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity (2007) 2.15
Complete genome sequence of the fish pathogen Flavobacterium psychrophilum. Nat Biotechnol (2007) 2.06
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol (2011) 2.01
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet (2005) 1.99
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol (2009) 1.87
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol (2008) 1.78
CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol (2006) 1.77
Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet (2006) 1.74
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet (2001) 1.70
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut (2012) 1.64
Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol (2006) 1.55
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol (2004) 1.49
Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner. Eur J Immunol (2013) 1.45
Stable isotopes (delta13C and delta15N) of organic matrix from coral skeleton. Proc Natl Acad Sci U S A (2005) 1.44
A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol (2005) 1.43
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
A metagenomic insight into our gut's microbiome. Gut (2012) 1.43
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin Cancer Res (2010) 1.42
Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep (2005) 1.41
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats. Br J Nutr (2007) 1.38
The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr (2006) 1.35
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest (2004) 1.33
Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr (2010) 1.33
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
Anaerobic sulfatase-maturating enzymes: radical SAM enzymes able to catalyze in vitro sulfatase post-translational modification. J Am Chem Soc (2007) 1.32
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol (2011) 1.31
MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol (2013) 1.30
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. Stat Med (2007) 1.29
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest (2012) 1.27
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy (2013) 1.27
A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat Genet (2002) 1.22
A new type of bacterial sulfatase reveals a novel maturation pathway in prokaryotes. J Biol Chem (2006) 1.22
Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut (2011) 1.20
Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect Immun (2010) 1.20
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
Population structure of the fish-pathogenic bacterium Flavobacterium psychrophilum. Appl Environ Microbiol (2008) 1.15
Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos (2008) 1.15
Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol (2010) 1.15
Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol (2007) 1.12
Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell (2013) 1.11
Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis (2002) 1.11
Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol (2009) 1.09
2,2'-[o-Phenylenebis(methylenethio)]bis(pyridine N-oxide). Acta Crystallogr Sect E Struct Rep Online (2009) 1.09
A one-dimensional cadmium(II) complex supported by a sulfur-nitro-gen mixed-donor ligand. Acta Crystallogr Sect E Struct Rep Online (2009) 1.07